NK Cell Therapy Recurrent/Refractory Elderly AML
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- AML
- Elderly
- Recurrent
- Refractory
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 60 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04599452
- Collaborators
- Not Provided
- Investigators
- Study Director: Chengyun Zheng, Ph.D. The Second Hospital of Shandong University
Get Well Soon